サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ラボオートメーションの世界市場の評価：製品別、用途別、エンドユーザー別、地域別、機会、予測（2016年～2030年）
市場調査レポート
商品コード
1328989

ラボオートメーションの世界市場の評価：製品別、用途別、エンドユーザー別、地域別、機会、予測（2016年～2030年）

Lab Automation Market Assessment, By Product By Application, By End User, By Region, Opportunities and Forecast, 2016-2030F

出版日
ページ情報
英文 127 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
ラボオートメーションの世界市場の評価：製品別、用途別、エンドユーザー別、地域別、機会、予測（2016年～2030年）
出版日: 2023年08月14日
発行: Market Xcel - Markets and Data
ページ情報: 英文 127 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のラボオートメーションの市場規模は、2022年の57億5,000万米ドルから2030年に98億2,000万米ドルに達し、2023年～2030年の予測期間にCAGRで6.92%の成長が予測されています。市場は、主に研究機器に関する技術の進歩や、製薬と研究開発機関における自動化ラボシステムの採用の増加により、当面は大きな成長が見込まれます。さらに、コンパクトな処理機器に対する需要の高まりも市場拡大の一因となっています。しかし、多額の初期投資が必要であることが、市場成長を阻害しています。

市場企業による投資と戦略的取り組みの拡大

市場は、ヒューマンエラーを排除する専門かつ先進のオートメーションサービスへの高い需要により、大幅な成長を示しています。市場企業は自動化ラボインフラの開発と製造をサポートするため、多様なツール、機器、機械、技術を提供することを優先しています。より大きな世界市場シェアを獲得するため、市場企業は追加投資を行い、先進の技術と手法を開発するための資金を確保しています。

ラボラトリーロボットが主要セグメントとして台頭

ラボラトリーロボットは、市場において変革力として台頭し、市場の大きな成長機会をもたらしています。科学研究の複雑化とハイスループットスクリーニングの需要の高まりにより、製薬、バイオテクノロジー、医療、研究機関などのさまざまな業界でラボラトリーロボットの採用が加速しています。

創薬と医薬品開発に向けた自動化器具の使用の増加

市場では、創薬と医薬品開発に自動化器具を使用するケースが大幅に増加しています。この動向は、ラボのワークフローにおける効率性、正確性、生産性の向上において、自動化が提供する利点に対する認識の高まりを反映しています。近年、創薬はラボオートメーション統合の大幅な増加を示しており、製薬研究の方法に革命をもたらしています。新しいより効果的な治療法への需要がますます高まる中、自動化は医薬品開発プロセスを加速し、全体的な効率を向上させる重要なツールとして浮上しています。

主要企業の状況と見通し

市場は、革新と成長を促進する複数の主要企業によってダイナミックな見通しを提示しています。Thermo Fisher Scientific、Agilent Technologies、Siemens Healthineers、PerkinElmerなどの主要企業は、広範な製品ポートフォリオと市場での強いプレゼンスにより、市場を独占しています。これらの企業は、先進の自動化技術とソリューションを導入するため、継続的に研究開発に投資しています。市場の見通しは、合理化されたラボワークフロー、効率性の向上、データ精度の改善に対する需要が高まり続けているため、引き続き有望です。ロボットシステム、AI、クラウドベースのオートメーションプラットフォームなどの技術の進歩が、市場の将来を形成すると予測されます。さらに、提携、パートナーシップ、戦略的買収によって競合が激化し、市場成長がさらに促進される可能性が高いです。

当レポートでは、世界のラボオートメーション市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 世界のラボオートメーション市場に対するCOVID-19の影響

第4章 エグゼクティブサマリー

第5章 世界のラボオートメーション市場の見通し（2016年～2030年）

  • 市場規模と予測
    • 金額
  • 製品別
    • 自動ワークステーション
    • 自動統合ワークステーション
    • ピペッティングシステム
    • 試薬ディスペンサー
    • マイクロプレートウォッシャー
    • マルチモードマイクロプレートリーダー
    • フィルターベース
    • モノクロメーターベース
    • ハイブリッド
    • シングルモードマイクロプレートリーダー
    • 蛍光
    • 吸光
    • 発光
    • 既製の自動ワークセル
    • ソフトウェア
    • ロボットシステム
    • 自動ストレージ検索システム
    • その他
  • 用途別
    • 創薬
    • 診断
  • エンドユーザー別
    • バイオテクノロジー企業、製薬企業
    • 病院、診断研究所
    • 研究、学術機関
    • 法医学研究所
    • 環境、検査研究所
    • 食品・飲料産業
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 南米
    • 中東・アフリカ
  • 市場シェア：企業別（2022年）

第6章 世界のラボオートメーション市場の見通し：地域別（2016年～2030年）

  • 北米
    • 製品別
    • 用途別
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • 英国
    • ロシア
    • オランダ
    • スペイン
    • トルコ
    • ポーランド
  • 南米
    • ブラジル
    • メキシコ
    • アルゼンチン
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • オーストラリア
    • ベトナム
    • 韓国
    • インドネシア
    • フィリピン
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ

第7章 市場マッピング（2022年）

  • コンポーネント別
  • 技術別
  • エンドユーザー別
  • 製品別
  • 地域別

第8章 マクロ環境と産業構造

  • 需給分析
  • 輸出入の分析 - 数量と金額
  • サプライ/バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第9章 市場力学

  • 成長促進要因
  • 成長抑制要因（課題、抑制要因）

第10章 規制の枠組みとイノベーション

  • 臨床試験
  • 特許の情勢
  • 規制当局の承認
  • イノベーション/最新技術

第11章 主要企業情勢

  • マーケットリーダー上位5社の競合マトリクス
  • マーケットリーダー上位5社市場の収益分析（2022年）
  • 合併と買収/合弁事業（該当する場合）
  • SWOT分析（市場参入企業5社向け）
  • 特許分析（該当する場合）

第12章 価格分析

第13章 ケーススタディ

第14章 主要企業の見通し

  • Agilent Technologies
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd
  • PerkinElmer Inc
  • Abbott Laboratories
  • Aurora Biomed Inc
  • Biomerieux
  • Azenta US Inc
  • Danaher Corporation
  • Eppendorf SE
  • Hamilton Company
  • Hudson Robotics
  • Lablynx Lims
  • Labvantage Solutions INC.
  • Qiagen N.V
  • Siemens Healthcare GMBH

第15章 戦略的推奨事項

第16章 当社について・免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 2. Global Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 3. Global Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 4. Global Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 5. Global Lab Automation Market Share, By Region, In USD Billion, 2016-2030F
  • Figure 6. North America Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 7. North America Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 8. North America Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 9. North America Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 10. North America Lab Automation Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 11. United States Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 12. United States Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 13. United States Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 14. United States Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 15. Canada Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 16. Canada Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 17. Canada Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 18. Canada Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 19. Mexico Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 20. Mexico Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 21. Mexico Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 22. Mexico Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 23. Europe Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 24. Europe Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 25. Europe Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 26. Europe Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 27. Europe Lab Automation Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 28. Germany Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 29. Germany Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 30. Germany Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 31. Germany Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 32. France Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 33. France Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 34. France Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 35. France Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 36. Italy Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 37. Italy Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 38. Italy Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 39. Italy Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 40. United Kingdom Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 41. United Kingdom Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 42. United Kingdom Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 43. United Kingdom Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 44. Russia Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 45. Russia Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 46. Russia Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 47. Russia Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 48. Netherlands Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 49. Netherlands Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 50. Netherlands Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 51. Netherlands Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 52. Spain Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 53. Spain Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 54. Spain Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 55. Spain Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 56. Turkey Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 57. Turkey Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 58. Turkey Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 59. Turkey Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 60. Poland Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 61. Poland Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 62. Poland Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 63. Poland Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 64. South America Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 65. South America Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 66. South America Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 67. South America Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 68. South America Lab Automation Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 69. Brazil Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 70. Brazil Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 71. Brazil Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 72. Brazil Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 73. Argentina Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 74. Argentina Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 75. Argentina Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 76. Argentina Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 77. Asia-Pacific Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 78. Asia-Pacific Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 79. Asia-Pacific Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 80. Asia-Pacific Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 81. Asia- Pacific Cream Market Share, By End-use Industry, In USD Billion, 2016-2030F
  • Figure 82. Asia-Pacific Lab Automation Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 83. India Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 84. India Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 85. India Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 86. India Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 87. China Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 88. China Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 89. China Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 90. China Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 91. Japan Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 92. Japan Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 93. Japan Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 94. Japan Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 95. Australia Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 96. Australia Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 97. Australia Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 98. Australia Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 99. Vietnam Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 100. Vietnam Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 101. Vietnam Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 102. Vietnam Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 103. South Korea Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 104. South Korea Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 105. South Korea Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 106. South Korea Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 107. Indonesia Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 108. Indonesia Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 109. Indonesia Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 110. Indonesia Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 111. Philippines Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 112. Philippines Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 113. Philippines Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 114. Philippines Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 115. Middle East & Africa Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 116. Middle East & Africa Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 117. Middle East & Africa Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 118. Middle East & Africa Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 119. Middle East & Africa Lab Automation Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 120. Saudi Arabia Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 121. Saudi Arabia Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 122. Saudi Arabia Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 123. Saudi Arabia Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 124. UAE Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 125. UAE Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 126. UAE Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 127. UAE Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 128. South Africa Lab Automation Market, By Value, In USD Billion, 2016-2030F
  • Figure 129. South Africa Lab Automation Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 130. South Africa Lab Automation Market Share, By Application, In USD Billion, 2016-2030F
  • Figure 131. South Africa Lab Automation Market Share, By End-User, In USD Billion, 2016-2030F
  • Figure 132. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 133. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 134. By End-User Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 135. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2022
目次
Product Code: MX10280

Global Lab Automation Market size was valued at USD 5.75 billion in 2022 and is expected to reach USD 9.82 billion in 2030 with a CAGR of 6.92% for the forecast period between 2023 and 2030. Lab automation is a cutting-edge and interdisciplinary method employed in labs to enhance productivity, minimize time consumption, and improve efficiency in laboratory procedures. The market for lab automation is expected to experience significant growth in the foreseeable future, primarily driven by advancements in technology about laboratory equipment and the increasing adoption of automated laboratory systems in pharmaceutical and research and development (R&D) institutes. Furthermore, the growing demand for compact processing equipment is also a contributing factor to the expansion of the market. However, the substantial initial investment requirement impeded the market's growth.

The lab automation market is witnessing a surge in demand globally, driven by the rapid advancement of technology. Lab automation equipment and tools are extensively utilized in the healthcare sector. With healthcare expenditures rising due to various factors, prominent pharmaceutical and healthcare companies are being propelled to automate their laboratories. This enables them to provide advanced healthcare services conveniently and efficiently, saving time and bringing healthcare services closer to people's doorsteps.

The surging demand for healthcare services has fueled intense competition among leading healthcare and pharmaceutical companies globally to undergo lab automation. This competition has increased the utilization of equipment, analyzers, and software in laboratory settings. Market players are primarily focused on offering a wide range of tools, equipment, machines, and techniques to facilitate the development and manufacturing of automated laboratory infrastructure. To achieve this, market players are making substantial investments and securing funding to develop advanced technologies and methodologies.

Growing Investments and Strategic Initiatives by Market Players

The lab automation market is witnessing significant growth due to the high demand for specialized and advanced automated services that eliminate human errors. Both market players and companies prioritize providing diverse tools, equipment, machines, and techniques to support the development and manufacturing of automated laboratory infrastructure. This market expansion is driven by the increasing demand for specialized advanced automated services that can effectively eliminate human error. To capture a larger global market share, market players are making additional investments and securing funding to develop advanced technologies and methodologies. Their primary focus is to reduce manual efforts and hands-on time in traditionally labor-intensive processes.

In June 2022, BD announced the successful completion of the acquisition of Straub Medical AG, a privately owned company. This acquisition has enabled BD to gain valuable expertise and experience of Straub Medical AG while expanding its product portfolio.

In January 2022, Qiagen made two partnership announcements. The first collaboration was with Atila BioSystems, aimed at offering non-invasive prenatal testing solutions to Qiagen's dPCR franchise. The second announcement involved a co-exclusive licensing and co-marketing agreement with Actome GmbH, a life sciences start-up from Germany. This agreement expanded Qiacuity's scope beyond genomics and proteomics.

Laboratory Robotics has Emerged as a Pivotal Segment

Laboratory robotics has emerged as a transformative force in the lab automation market, presenting an excellent opportunity for substantial market growth. Integrating robotics in laboratory processes has revolutionized scientific experiments and tasks, offering numerous advantages over traditional manual methods. By automating repetitive and time-consuming tasks, laboratory robotics boosts efficiency and reduces the risk of human error, enhancing overall data accuracy and reliability. The increasing complexity of scientific research and the growing demand for high-throughput screening have accelerated the adoption of laboratory robotics in various industries, including pharmaceuticals, biotechnology, healthcare, and research institutions.

With exceptional precision and speed, these robotics systems can handle various tasks, such as sample handling, liquid handling, plate manipulation, and data analysis. Additionally, laboratory robotics facilitate improved resource management, as they can operate around the clock, optimizing the utilization of expensive lab equipment and reagents. This, in turn, leads to cost savings and higher productivity, making them an attractive investment for companies and institutions seeking to streamline their laboratory workflows.

Opentrons, a leader in lab automation, launched Opentrons Flex robot in May 2023. Opentrons Flex robot is a new generation, affordable and easy-to-program liquid-handling lab robot designed to level the playing field for labs of all sizes and bring advanced lab automation to more researchers than ever before.

Technological Advancements

The global lab automated market is witnessing remarkable technological advancements, revolutionizing laboratory processes and research methodologies. One key area of progress is the integration of robotics and automation systems, which has significantly improved the efficiency and accuracy of laboratory tasks. Robotic systems can perform repetitive and complex operations with precision, reducing human errors and increasing productivity. Moreover, developing advanced sensors, software, and connectivity solutions has facilitated real-time monitoring, remote access, and seamless data exchange, fostering collaboration among researchers worldwide.

In November 2022, F. Hoffmann -La Roche Ltd. entered into a collaboration with PathAI to improve patient care through utilization of artificial intelligence-based digital pathology applications. As per the agreement for development and distribution, the companies will collaborate on creating an integrated image analysis process specifically designed for pathologists. This process will enable pathologists to use PathAI image analysis algorithms directly within Roche's uPath enterprise software, specifically its cloud-based NAVIFY Digital Pathology version.

Increasing Use of Automated Instruments for Drug Discovery and Development

The global lab automation market has witnessed a substantial rise in using automated instruments for drug discovery and development. This trend reflects the growing recognition of the advantages offered by automation in enhancing efficiency, accuracy, and productivity in laboratory workflows. In recent years, drug discovery has witnessed a substantial increase in the integration of lab automation, revolutionizing the way pharmaceutical research is conducted. With the ever-growing demand for novel and more effective therapeutics, automation has emerged as a crucial tool to accelerate the drug development process and improve overall efficiency. Automation streamlines various aspects of drug discovery, including high-throughput screening of potential drug compounds, compound synthesis and optimization, and data analysis.

Insilico Medicine, a clinical-stag e company focusses on utilizing artificial intelligence (AI) throughout the drug discovery process, revealed the successful conclusion of its Series D funding round. The company raised USD 60 million from a syndicate of global investors. The capital raised in the round further bolstered Insilico's financial position and fuelled the growth of its advancing pipeline. This included their lead program, which was undergoing a Phase I study at the time, as well as the continued development of their Pharma AI platform.

Impact of COVID-19

COVID-19 had a significant impact on the Global lab automation market. The virus outbreak increased the demand for diagnostic testing and research on potential treatments and vaccines. As a result, laboratories worldwide faced a surge in workload and the need for faster and more efficient processes. Lab automation technologies were crucial in meeting these demands by enabling high-throughput testing, sample processing, and data analysis. Automation systems streamlined workflows, reduced manual labour, and minimized the risk of human error, ensuring accurate and timely results. Additionally, the pandemic highlighted the importance of remote monitoring and operation of lab equipment, leading to adoption of cloud-based automation solutions.

In January 2022, the Hubrecht Institute and Genmab developed the 'STRIP-1' test robot, which can analyze 20,000 samples for SARS-CoV-2 testing within a span of 24 hours. This makes the STRIP-1 significantly faster than any other existing system. STRIP-1 can operate effectively with minimal volumes, utilizing smaller quantities of the currently scarce materials worldwide. Additionally, the expenses associated with each test conducted using STRIP-1 will be significantly lower compared to the prevailing testing costs.

Key Players Landscape and Outlook

The global lab automation market presents a dynamic landscape with several key players driving innovation and growth. Major companies such as Thermo Fisher Scientific, Agilent Technologies, Siemens Healthineers, and PerkinElmer dominate the market due to their extensive product portfolios and strong market presence. These players continuously invest in research and development to introduce advanced automation technologies and solutions. The global lab automation market outlook remains promising as the demand for streamlined laboratory workflows, enhanced efficiency, and improved data accuracy continues to rise. Technological advancements, such as robotic systems, artificial intelligence, and cloud-based automation platforms, are expected to shape the market's future. Moreover, collaborations, partnerships, and strategic acquisitions will likely intensify competition and further fuel market growth.

PerkinElmer, Inc. introduced readily available Adeno-associated Virus Vectors (AAV) Detection Kits in 2022, assisting scientists in gene therapy research for diverse severe illnesses. These high-throughput viral assays are purposefully developed to expedite and simplify the characterization of viral vector particles, aiding researchers in making informed decisions for secure and effective gene transfer.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19 on the Global Lab Automation Market

4. Executive Summary

5. Global Lab Automation Market Outlook, 2016-2030F

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. By Product
    • 5.2.1. Automated Workstation
      • 5.2.1.1. Automated Liquid handling system
    • 5.2.2. Automated Integrated Workstations
    • 5.2.3. Pipetting Systems
    • 5.2.4. Reagent Dispensers
    • 5.2.5. Microplate Washer
    • 5.2.6. Multimode Microplate Readers
    • 5.2.7. Filter Based
    • 5.2.8. Monochromator Based
    • 5.2.9. Hybrid
    • 5.2.10. Single mode microplate readers
    • 5.2.11. Fluorescence
    • 5.2.12. Absorbance
    • 5.2.13. Luminescence
      • 5.2.13.1. Automated ELISA System
      • 5.2.13.2. Automated Nucleic Acid purification system
    • 5.2.14. Off the shelf automated work cells
      • 5.2.14.1. Pre analytical automation
      • 5.2.14.2. Post analytical automation.
      • 5.2.14.3. Total Lab automation
    • 5.2.15. Software
      • 5.2.15.1. LIMS
      • 5.2.15.2. ELN
      • 5.2.15.3. LES
      • 5.2.15.4. SDMS
    • 5.2.16. Robotic System
      • 5.2.16.1. Robotic arm
      • 5.2.16.2. Track Robots
    • 5.2.17. Automated storage retrieval systems
    • 5.2.18. Others
  • 5.3. By Application
    • 5.3.1. Drug Discovery
      • 5.3.1.1. ADME Screening
      • 5.3.1.2. High Throughput Screening
      • 5.3.1.3. Compound Management
      • 5.3.1.4. Compound Weighing and Dissolution
      • 5.3.1.5. Others
    • 5.3.2. Diagnostics
      • 5.3.2.1. Pre-Analytics/Sample Preparation
      • 5.3.2.2. Sample Distribution, Splitting and Archiving
      • 5.3.2.3. EIA
      • 5.3.2.4. Genomics Solutions
      • 5.3.2.5. Proteomics Solutions
      • 5.3.2.6. Microbiology
      • 5.3.2.7. Others
  • 5.4. By End-user
    • 5.4.1. Biotechnology and Pharmaceutical companies
    • 5.4.2. Hospital and Diagnostic Laboratories
    • 5.4.3. Research and Academic Institutes
    • 5.4.4. Forensic Laboratories
    • 5.4.5. Environmental and testing laboratories
    • 5.4.6. Food and Beverages industry
  • 5.5. By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. South America
    • 5.5.5. Middle East & Africa
  • 5.6. By Company Market Share (%), 2022

6. Global Lab Automation Market Outlook, By Region, 2016-2030F

  • 6.1. North America*
    • 6.1.1. By Product
      • 6.1.1.1. Automated Workstation
      • 6.1.1.1.1. Automated Liquid handling system
      • 6.1.1.2. Automated Integrated Workstations
      • 6.1.1.3. Pipetting Systems
      • 6.1.1.4. Reagent Dispensers
      • 6.1.1.5. Microplate Washer
      • 6.1.1.6. Multimode Microplate Readers
      • 6.1.1.7. Filter Based
      • 6.1.1.8. Monochromator Based
      • 6.1.1.9. Hybrid
      • 6.1.1.10. Single Mode Microplate Readers
      • 6.1.1.11. Fluorescence
      • 6.1.1.12. Absorbance
      • 6.1.1.13. Luminescence
      • 6.1.1.13.1. Automated ELISA System
      • 6.1.1.13.2. Automated Nucleic Acid Purification System
      • 6.1.1.14. Off the shelf automated Work Cells
      • 6.1.1.14.1. Pre analytical Automation
      • 6.1.1.14.2. Post analytical Automation.
      • 6.1.1.14.3. Total Lab Automation
      • 6.1.1.15. Software
      • 6.1.1.15.1. LIMS
      • 6.1.1.15.2. ELN
      • 6.1.1.15.3. LES
      • 6.1.1.15.4. SDMS
      • 6.1.1.16. Robotic System
      • 6.1.1.16.1. Robotic Arm
      • 6.1.1.16.2. Track Robots
      • 6.1.1.17. Automated Storage Retrieval Systems
      • 6.1.1.18. Others
    • 6.1.2. By Application
      • 6.1.2.1. Drug Discovery
      • 6.1.2.1.1. ADME Screening
      • 6.1.2.1.2. High Throughput Screening
      • 6.1.2.1.3. Compound Management
      • 6.1.2.1.4. Compound Weighing and Dissolution.
      • 6.1.2.1.5. Others
      • 6.1.2.2. Diagnostics
      • 6.1.2.2.1. Pre-Analytics/Sample Preparation
      • 6.1.2.2.2. Sample Distribution, Splitting and Archiving
      • 6.1.2.2.3. EIA
      • 6.1.2.2.4. Genomics Solutions
      • 6.1.2.2.5. Proteomics Solutions
      • 6.1.2.2.6. Microbiology
      • 6.1.2.2.7. Others
      • 6.1.2.3. By End-user
      • 6.1.2.3.1. Biotechnology and Pharmaceutical Companies
      • 6.1.2.3.2. Hospital and Diagnostic Laboratories
      • 6.1.2.3.3. Research and Academic Institutes
      • 6.1.2.3.4. Forensic Laboratories
      • 6.1.2.3.5. Environmental and Testing Laboratories
      • 6.1.2.3.6. Food and Beverages Industry
    • 6.1.3. United States*
      • 6.1.3.1. By Product
      • 6.1.3.1.1. Automated Workstation
      • 6.1.3.1.1.1. Automated Liquid handling system
      • 6.1.3.1.2. Automated Integrated Workstations
      • 6.1.3.1.3. Pipetting Systems
      • 6.1.3.1.4. Reagent Dispensers
      • 6.1.3.1.5. Microplate Washer
      • 6.1.3.1.6. Multimode Microplate Readers
      • 6.1.3.1.7. Filter Based
      • 6.1.3.1.8. Monochromator Based
      • 6.1.3.1.9. Hybrid
      • 6.1.3.1.10. Single Mode Microplate Readers
      • 6.1.3.1.11. Fluorescence
      • 6.1.3.1.12. Absorbance
      • 6.1.3.1.13. Luminescence
      • 6.1.3.1.13.1. Automated ELISA System
      • 6.1.3.1.13.2. Automated Nucleic Acid Purification System
      • 6.1.3.1.13.3. Off the shelf automated Work Cells
      • 6.1.3.1.13.4. Pre analytical Automation
      • 6.1.3.1.13.5. Post analytical Automation.
      • 6.1.3.1.13.6. Total Lab Automation
      • 6.1.3.1.14. Software
      • 6.1.3.1.14.1. LIMS
      • 6.1.3.1.14.2. ELN
      • 6.1.3.1.14.3. LES
      • 6.1.3.1.14.4. SDMS
      • 6.1.3.1.15. Robotic System
      • 6.1.3.1.15.1. Robotic Arm
      • 6.1.3.1.15.2. Track Robots
      • 6.1.3.1.16. Automated Storage Retrieval Systems
      • 6.1.3.1.17. Others
      • 6.1.3.2. By Application
      • 6.1.3.2.1.1. Drug Discovery
      • 6.1.3.2.1.2. ADME Screening
      • 6.1.3.2.1.3. High Throughput Screening
      • 6.1.3.2.1.4. Compound Management
      • 6.1.3.2.1.5. Compound Weighing and Dissolution.
      • 6.1.3.2.1.6. Others
      • 6.1.3.2.2. Diagnostics
      • 6.1.3.2.2.1. Pre-Analytics/Sample Preparation
      • 6.1.3.2.2.2. Sample Distribution, Splitting and Archiving
      • 6.1.3.2.2.3. EIA
      • 6.1.3.2.2.4. Genomics Solutions
      • 6.1.3.2.2.5. Proteomics Solutions
      • 6.1.3.2.2.6. Microbiology
      • 6.1.3.2.2.7. Other
      • 6.1.3.3. By End-user
      • 6.1.3.3.1.1. Biotechnology and Pharmaceutical Companies
      • 6.1.3.3.1.2. Hospital and Diagnostic Laboratories
      • 6.1.3.3.1.3. Research and Academic Institutes
      • 6.1.3.3.1.4. Forensic Laboratories
      • 6.1.3.3.1.5. Environmental and Testing Laboratories
      • 6.1.3.3.1.6. Food and Beverages Industry
    • 6.1.4. Canada
    • 6.1.5. Mexico

All segments will be provided for all regions and countries covered

  • 6.2. Europe
    • 6.2.1. Germany
    • 6.2.2. France
    • 6.2.3. Italy
    • 6.2.4. United Kingdom
    • 6.2.5. Russia
    • 6.2.6. Netherlands
    • 6.2.7. Spain
    • 6.2.8. Turkey
    • 6.2.9. Poland
  • 6.3. South America
    • 6.3.1. Brazil
    • 6.3.2. Mexico
    • 6.3.3. Argentina
  • 6.4. Asia-Pacific
    • 6.4.1. India
    • 6.4.2. China
    • 6.4.3. Japan
    • 6.4.4. Australia
    • 6.4.5. Vietnam
    • 6.4.6. South Korea
    • 6.4.7. Indonesia
    • 6.4.8. Philippines
  • 6.5. Middle East & Africa
    • 6.5.1. Saudi Arabia
    • 6.5.2. UAE
    • 6.5.3. South Africa

7. Market Mapping, 2022

  • 7.1. By Component
  • 7.2. By Technology
  • 7.3. By End-User
  • 7.4. By Product
  • 7.5. By Region

8. Macro Environment and Industry Structure

  • 8.1. Supply Demand Analysis
  • 8.2. Import Export Analysis - Volume and Value
  • 8.3. Supply/Value Chain Analysis
  • 8.4. PESTEL Analysis
    • 8.4.1. Political Factors
    • 8.4.2. Economic System
    • 8.4.3. Social Implications
    • 8.4.4. Technological Advancements
    • 8.4.5. Environmental Impacts
    • 8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 8.5. Porter's Five Forces Analysis
    • 8.5.1. Supplier Power
    • 8.5.2. Buyer Power
    • 8.5.3. Substitution Threat
    • 8.5.4. Threat from New Entrant
    • 8.5.5. Competitive Rivalry

9. Market Dynamics

  • 9.1. Growth Drivers
  • 9.2. Growth Inhibitors (Challenges, Restraints)

10. Regulatory Framework and Innovation

  • 10.1. Clinical Trials
  • 10.2. Patent Landscape
  • 10.3. Regulatory Approvals
  • 10.4. Innovations/Emerging Technologies

11. Key Players Landscape

  • 11.1. Competition Matrix of Top Five Market Leaders
  • 11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2022)
  • 11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4. SWOT Analysis (For Five Market Players)
  • 11.5. Patent Analysis (If Applicable)

12. Pricing Analysis

13. Case Studies

14. Key Players Outlook

  • 14.1. Agilent Technologies
    • 14.1.1. Company Details
    • 14.1.2. Key Management Personnel
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As reported)
    • 14.1.5. Key Market Focus & Geographical Presence
    • 14.1.6. Recent Developments
  • 14.2. Becton, Dickinson and Company
  • 14.3. Thermo Fisher Scientific, Inc.
  • 14.4. F. Hoffmann-La Roche Ltd
  • 14.5. PerkinElmer Inc
  • 14.6. Abbott Laboratories
  • 14.7. Aurora Biomed Inc
  • 14.8. Biomerieux
  • 14.9. Azenta US Inc
  • 14.10. Danaher Corporation
  • 14.11. Eppendorf SE
  • 14.12. Hamilton Company
  • 14.13. Hudson Robotics
  • 14.14. Lablynx Lims
  • 14.15. Labvantage Solutions INC.
  • 14.16. Qiagen N.V
  • 14.17. Siemens Healthcare GMBH

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15. Strategic Recommendations

16. About Us & Disclaimer